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Abstract 
Background: Mathematical models can be useful tools in exploring disease trends and health 
consequences of interventions in a population over time. Most cancers, in particular cervical 
cancer, have long incubation periods. The time from acquisition of HPV infection to devel-
opment of invasive cancer can be up to two decades or more. Mathematical models can be 
used to translate short-term findings from prevention and mitigations trials into predictions of 
long-term health outcomes. The main objective of this paper is to develop a mathematical 
model of HPV for African American women (AAW) in the United States and give quantitative 
insight into current U.S. prevention and mitigations against cervical cancer.  
Methods:  A compartmental mathematical model of the cycle of HPV that includes the 
choices individuals make once they become infected; treatment versus no treatment, was 
developed. Using this mathematical model we evaluated the impact of human papillomavirus 
(HPV) on a given population and determined what could decrease the rate at which AAW 
become infected. All state equations in the model were approximated using the Runge-Kutta 
4
th order numerical approximation method using MatLab software.  
Results: In this paper we found that the basic reproductive number ROU is directly propor-
tional to the rate of infectivity of HPV and the contact rate in which a human infects another 
human with HPV. The ROU was indirectly proportional to the recovery rate plus the mortality 
by natural causes and the disease. The second ROT is also directly proportional to the rate of 
infectivity of HPV and contact rate in which humans infect another human with HPV and in-
directly proportional to the recovery rate plus the mortality from HPV related cause and 
natural causes. Based on the data of AAW for the parameters; we found that ROU and ROT were 
0.519798 and 0.070249 respectively. As both of these basic reproductive numbers are less 
than one, infection cannot therefore get started in a fully susceptible population, however, if 
mitigation is to be implemented effectively it should focus on the HPV untreated population as 
ROT is greater than 0.5. 
Conclusion: Mathematical models, from individual and population perspectives, will help 
decision makers to evaluate different prevention and mitigation measures of HPV and deploy 
synergistically to improve cancer outcomes. Integrating the best-available epidemiologic data, 
computer-based mathematical models used in a decision-analytic framework can identify 
those factors most likely to influence outcomes and can help in formulating decisions that 
need to be made amidst considerable lack of data and uncertainty. Specifically, the model 
provides a tool that can accommodate new information, and can be modified as needed, to 
iteratively assess the expected benefits, costs, and cost-effectiveness of different policies in 
the United States. This model can help show the direct relationship between HPV and cervical 
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cancer. If any of the rates change it will greatly impact the graphs. These graphs can be used to 
discover new methods of treatment that will decrease the rate of infectivity of HPV and 
Cervical cancer with time. 
Key words: Human Papillomavirus (HPV), reproductive number. 
Introduction 
Genital Human papillomavirus (HPV) is one of 
the  most  common  sexually  transmitted  infections 
(STI) [1] and has been shown in epidemiological and 
molecular studies to be a necessary etiologic agent for 
cervical  cancer  [1-3].  The virus  infects  the  skin  and 
mucous  membranes.  There  are  more  than  40  HPV 
types  that  can  infect  the  genital  areas  of  men  and 
women, including the skin of the penis, vulva (area 
outside the vagina), and anus, and the linings of the 
vagina, cervix, and rectum. Most people who become 
infected with HPV do not even know that they have it. 
The HPV type 16 is the most common high-risk type, 
accounting  for  more  than  half  (56%)  of  all  cervical 
cancers [4]. Persistent infection with high-risk types of 
HPV  is  the  most  important  risk  factor  for  cervical 
cancer [5]. The long premalignant course of HPV in-
fection means that screening programs can detect and 
treat early disease and prevent progression to cervical 
cancer.  
In  the  United  States,  approximately  20  million 
Americans are currently infected with HPV, and an-
other 6.2 million people become newly infected each 
year. At least 50% of sexually active men and women 
acquire genital HPV infection at some point in their 
lives [1]. Almost half of the infections are in people 
between 15 and 25 years of age [6]. 
Genital HPV is spread mainly by direct genital 
contact during vaginal, oral and/or anal sex. It is not 
spread through blood or body fluids. Infection is very 
common soon after a woman becomes sexually active. 
Oral-genital  and  hand-genital  transmission  of  some 
genital HPV types is possible and has been reported. 
Transmission from mother to newborn during deliv-
ery is rare. When it occurs, it can cause warts in the 
infant's throat called respiratory papillomatosis [6].  
Genital HPV usually has no symptoms, unless it 
is a type that causes genital warts. Genital warts may 
appear within weeks or months after contact with a 
partner who has HPV. Most people will never know 
they have HPV because they have no symptoms and 
the body's immune system causes the virus to become 
inactive.  A  small  number  of  people  with  HPV  will 
have the virus for longer periods of time [6].  
About 99% of all cervical cancers are related to 
HPV. Of these, about 70% are caused by HPV types 16 
or 18. About 500,000 pre-cancerous cell changes of the 
cervix, vagina, and vulva are diagnosed each year in 
the United States, and over half are related to HPV 16 
and 18 [7]. Although all cervical cancers are related to 
HPV, most genital HPV infections do not cause cer-
vical  cancer.  Research  studies  indicate  that,  most 
people who test positive for genital HPV DNA test 
negative later on, often within a 6 to 12 months period 
[1].  
HPV  cannot  be  treated,  but  most  genital  HPV 
infections resolve with the help of the body’s immune 
system. About 70% of HPV infections appear to go 
away within a year and 90% within 2 years. Although 
HPV itself cannot be treated, the cellular changes that 
come from an HPV infection can be treated. For ex-
ample, genital warts can be treated. Pre-cancerous cell 
changes caused by HPV can be detected by Pap tests 
and  treated.  Cervical,  anal,  and  genital  cancers  can 
also be treated.  
Getting the HPV vaccine before being exposed to 
HPV will prevent some HPV infections. Limiting the 
number of sex partners and avoiding sex with people 
who have had many other sexual partners decreases a 
person's risk of exposure to HPV. Human papilloma 
virus infections are very common, these afore men-
tioned precautionary measures are no guarantee that 
a person will not get HPV. Still, these measures may 
help reduce the number of times a person is exposed 
to HPV.  
Condoms provide some, but not total, protection 
against  HPV.  The  virus  can  spread  during  direct 
skin-to-skin contact before the condom is put on, and 
male condoms do not cover the entire genital area, 
especially in women. The female condom covers more 
of the vulva in women but has not been studied as 
carefully for its ability to prevent HPV. Condoms are 
very helpful, though, in protecting from other infec-
tions that can be spread through sexual activity.  
In June of 2006, the Food and Drug Administra-
tion  (FDA)  approved  a  vaccine  that  prevents  the  2 
types of HPV (HPV 16 and 18) that cause 70% of all 
cervical cancers [7]. The vaccine also prevents 2 types 
of HPV (HPV 6 and 11) that cause 90% of all genital 
warts.  This  vaccine  is  named  Gardasil®.  In  October 
2009,  Bivalent  HPV  (HPV2)  which  prevents  the  2 
types of HPV (HPV 16 and 18) for females 10 through 
25  years  of  age  was  approved.  Over  the  next  few 
years,  we  can  expect  to  see  the  licensing  of  one  or 
more  prophylactic  vaccines  against  human  papillo- Journal of Cancer 2012, 3 
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mavirus  (HPV)  infection,  considered  a  necessary 
precursor to cervical cancer. 
HPV  infection  can  be  treated  if  detected  in  its 
earliest stages by annually having a papanicolaou test 
or pap smear, which is a scrapping of the cervix to 
detect abnormal cells [1]. Once dysplasia is noticed by 
genital warts, the individual should get a biopsy to 
better determine which region of the cervix is infect-
ed. Treatment options are freezing, laser surgery, or 
doing  nothing.  Sometimes  the  body  will  naturally 
heal itself but  that is a high risk to take. Typically, 
HPV infection can be treated, but for individuals who 
do not regularly visit a gynecologist to check if they 
are infected, have a higher risk of HPV infection ad-
vancing to cervical cancer. Women fail to get regular 
checkups for various reason such as fear, the idea that 
“nothing is wrong”, “I cannot possibly get that”, and 
lack  of  monetary  resources.  The  highest  number  of 
cervical cancer cases is found in resource poor popu-
lations of women in whom at least 80% of all incident 
cervical cancer and related mortality occurs [2]. They 
are  not  able  to  afford  proper  healthcare,  but  those 
who can should invest to prevent the HPV infection 
advancing to cervical cancer. 
Although cervical cancer can be prevented, it is 
still the number two cancer killer of women [7]. The 
cancer  begins  in  the  cervix,  the  lower  part  of  the 
uterus which extends to the vagina and is very im-
portant for child bearing and for controlling the blood 
flow during menstruation. Cervical cancer is caused 
by  squamous  or  adenocarcinoma  (non  squamous) 
tumors and if treated in its early stages, the five year 
survival rate is very high [6]. There are four stages of 
cervical cancer: Stage 1 non invasive, Stage 2 cancer 
spreads outside cervix, Stage 3 advanced extends to 
pelvic wall, and Stage 4 most advanced and spreads 
to other organs [1]. Even though cervical cancer oc-
curs  in  younger  women  it  is  mostly  common  in 
women between 35 and 55 years of age. These women 
tend to stop getting pap smears and do not realize 
they are at the most vulnerable ages. There are several 
available  treatments  for  cervical  cancer  including 
hysterectomy,  radiation,  and  chemotherapy.  Alt-
hough the cancer is a killer, women can overcome the 
cancer by taking better health precautions. 
Methods 
Mathematical  models,  from  individual  and 
population perspectives, will help decision makers to 
evaluate different prevention and mitigation scenari-
os  against  HPV  infection.  The  models  can  deploy 
synergistically  to  analyze  improvement  of  cancer 
outcomes,  reduce  disparities,  and  enhance  the 
cost-effectiveness  of  cervical  cancer  prevention, 
treatment and control. Integrating the best-available 
epidemiologic  data,  computer-based  mathematical 
models  used  in  a  decision-analytic  framework  can 
identify  those  factors  most  likely  to  influence  out-
comes. This can help decision makers in making de-
cisions that need to be made amidst considerable lack 
of  data  and  uncertainty  due  to  the  long  incubation 
period of cancer. 
Given  the  inevitable  uncertainty  around  input 
parameters  to  many  mathematical  models,  an  im-
portant feature of many modeling efforts is the eval-
uation of these parameter values in reference to ob-
served epidemiologic data. Our objectives in this pa-
per are to: (1) describe a formal approach to the pa-
rameterization, calibration, and evaluation of an HPV 
infection model for the AAW in the United States; and 
(2) use this model to predict health outcomes, as well 
as the uncertainty surrounding these predictions, as-
sociated with vaccination against HPV infection, and 
combinations of vaccination and screening. 
The Mathematical Modeling 
Based on the biology of HPV, and cervical can-
cer, we developed a system of sequence of differential 
equations that capture the dynamics of HPV and cer-
vical cancer. The system was then analyzed using the 
method of the next generator operator, with a basic 
reproduction number. Parameters were defined and 
estimated  (Table  1)  and  the  model  was  developed 
considering all possible scenarios which individuals 
might take in regard to HPV and cervical cancer mit-
igations. This is shown as a flow diagram in which the 
boxes represent the different compartments and the 
arrows show  the transitions between compartments 
(Figure 1). 
Many  diseases,  especially  diseases  caused  by 
viral agents, including HPV, smallpox, measles, and 
rubella (German measles), provide immunity against 
re-infection. Such diseases tend to occur in cycles of 
outbreaks due to the variation in number of suscepti-
ble  individuals.  In  our  model  we  used  a  compart-
mental  model  representing  the  progression  of  HPV 
disease from susceptible to HPV infection to cancer in 
five compartments. The susceptible population (S(t) 
over time) is African American Women older than 16. 
During an epidemic, the number of susceptible indi-
viduals falls rapidly as more of them are infected and 
thus  progress  to  either  the  infected  stage  receiving 
treatment  IHPVT(t)  (the  number  of  HPV  the  infected 
receiving treatment) or the infected stage receiving no 
treatment  IHPVU(t)  (the  number  of  HPV  infected  re-
ceiving  no  treatment).  Both  the  IHPVT(t)  and IHPVU(t) 
can then progress to either the class of cervical cancer 
population of treated (ICCT (t)) or untreated (ICCU (t)).  Journal of Cancer 2012, 3 
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However, it is indicated in the literature that also both 
the IHPVT(t) and IHPVU(t) can revert to the susceptible 
stage (S(t)). The disease cannot break out again until 
the numbers of susceptible have built back up as a 
result of new born added into the susceptible com-
partment at a rate of  and also as a result of the re-
version from IHPVT(t) and IHPVU(t). N is the total popu-
lation (the sum of all the state populations), and that 
ICC is the sum of ICCT (t) and ICCU (t). 
We derived the differential equations expressing 
the rate of change of the size of each of the five com-
partments of population. Using this model we evalu-
ate the impact of HPV on AAW population in US and 
determine what can decrease the rate in which AAW 
become  infected.  The  dynamics  of  the  relationships 
between the AAW population and HPV disease and 
the behaviors were described by means of ordinary 
differential equations. All state equations in the model 
were approximated using the Runge-Kutta 4th order 
numerical approximation method using MatLab. 
 
Table 1: Parameter list and their estimates. 
Parameter estimate  Parameter description  Reference(s) 
Δ = 16,821,072*  Human recruitment rate  [9] 
KH = 0.80  Rate at which humans infect other humans (effective contact rate)  [1] 
β = 0.0576  Per capita mortality rate of population  [9] 
HT = very close to 0  Mortality rate of individuals infected with HPV receiving treatment  [1-7] 
H = very close to 0  Mortality rate of individuals infected with HPV with no treatment  [1-7] 
CT = 0.05721  Mortality rate of individuals with cervical cancer receiving treatment  [7] 
C
 
= 0.00043  Mortality rate of individuals with cervical cancer with no treatment  [7] 
= 0.31  Rate of infectivity of HPV  [7] 
= 0.85 Rate of infectivity of HPV receiving treatment  [7] 
 = 0.15  Rate of infectivity of HPV receiving no treatment  [7] 
= 0.00035  Rate of change of infection from HPV with treatment to cervical cancer  [1-2] 
= 0.1271  Rate of change of infection from HPV with no treatment to cervical cancer  [1-2] 
= 0.30  Recovery rate from HPV infection with treatment  [6-7] 
= 0.70  Recovery rate from HPV infection without treatment  [6-7] 
*This is only the population of AAW 16 years and over in 2010. Men were not considered since they have no cervix. 
 
 
 
Figure 1. Systems Dynamic Model of HPV in causation of CC. 
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The  theory  of  biological  evolution  provides  a 
dynamic method for predicting past and future pop-
ulation  change.  If  we  know  a  population's  current 
composition and we can identify the fittest individu-
als, we can predict that population's future composi-
tion. However, when converting theory to prediction 
we stumble at one particular point: how does nature 
determine fitness? Fitness is a flexible concept that can 
be defined in different ways depending on the evolu-
tionary  problem  being  addressed.  The  evolutionary 
ecology concept of fitness is conventionally defined as 
the “reproductive success” of a phenotype or adapta-
tion.  In  infectious  disease  research,  the  most  com-
monly invoked measure of reproductive success is the 
basic reproductive number R0. 
R0 is commonly used in mathematical epidemi-
ology as summary statistics for the size and control-
lability  of  epidemics.  To  study  evolution  problems 
where the host population size is changing, measures 
like the ultimate proliferation rate must be used. For 
infectious  diseases,  this  means  the  number  of  new 
infections  caused  by  a  typical  case  in  a  completely 
susceptible  population.  In  several  archetypal  epide-
miology  models,  strains  of  disease  with  higher  R0 
values  out-compete  strains  with  lower  R0  values, 
leading to a rule-of-thumb that evolution maximizes 
R0.  
The next generation operator approach: R0 is of-
ten found through the study and computation of the 
eigenvalues of the Jacobian at the disease- or infec-
tious-free equilibrium. Diekmann [8] follow a differ-
ent approach called the next generation operator ap-
proach. They define R0 as the spectral radius of the 
“next  generation  operator”.  The  details  of  this  ap-
proach are outlined in the rest of this section. First, we 
consider the case where heterogeneity is discrete, that 
is,  the  case  where  heterogeneity  is  defined  using 
groups  defined  by  fixed  characteristics,  that  is,  for 
epidemiological  models  that  can  be  written  in  the 
form: 
 
) , , (
) , , (
) , , (
Z Y X h
dt
dZ
Z Y X g
dt
dY
Z Y X f
dt
dX



 
where X  IRr; Y  IRs, Z  IRn, r; s; n  0, and h(X; 
0; 0) = 0. The components of X denote the number of 
susceptibles,  recovered,  and  other  classes  of 
non-infected individuals. The components of  Y rep-
resent the number of infected individuals who do not 
transmit the disease (various latent or non-infectious 
stages). The components of Z represent the number of 
infected individuals capable of transmitting the dis-
ease  (e.g.,  infectious  and  non-quarentined  individu-
als). Let U0 = (X*; 0; 0)  IRr+s+n denote the disease-free 
equilibrium, that is, 
f(X*,0,0)=g(X*,0,0)=h(X*,0,0)=0. 
Assume that the equation g(X*; Y; Z) = 0 implic-
itly  determines  a  function  Y  =  ĝ(X*;  Y  ).  Let  A  = 
DZh(X*; ĝ(X*; 0); 0) and further assume that A can be 
written in the form A = M - D, with M  0 (that is, mij  
0) and D > 0, a diagonal matrix. 
The  spectral  bound  of  matrix  B  is  denoted  by 
m(B) = sup { : (B)}, where   means the real 
part  of  ,  while 

   n
n
n B lim ) B (  denotes  the 
spectral radius of B. The proof of the following theo-
rem involving matrix A is found in Diekmann [8]: 
Either   
m(A)<0  (MD-1)<1  
or   
m(A)>0  (MD-1)>1 
The  basic reproductive number  is  defined  as  the 
spectral radius (dominant eigenvalue) of the matrix 
MD-1, that is,  
R0 =(MD-1) 
Using a system of five differential equations the 
spread  of  HPV  infection  is  described,  based  on  the 
five compartments. When developing the model, we 
did not consider those cases where a susceptible in-
dividual becomes infected with cervical cancer, since 
those cases are rare. As IHPV is a transition compart-
ment and the time it takes to move to treated or un-
treated is shorter time scale as compared to the other 
five  compartment  and  hence  is  not  included  in  the 
system of differential equations. Listed below are the 
differential equations (DE) from the model. The posi-
tive terms are what are entering the compartment and 
the  negative  terms  are  what  are  leaving  the  com-
partment, respectively. 
 
 
 
CCU C HPVT HPVU CCU
CCT CT HPVU HPVT CCT
HT HPVT HPVT H HPVT
H HPVU HPVU H HPVU
HPVU HPVT HPVU HPVT H
I I I I
I I I I
I I
N
S
k I
I I
N
S
k I
S I I I I
N
S
k S
) ( ) 1 ( ) 1 (
) (
) 1 (
) 1 (
3 4
4 3
5 1
6 2
6 5 2 1
   
   
   
   
    
     
   
    
    
      





 
Two vectors, V and F were used to find R0.  Journal of Cancer 2012, 3 
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












0 0 0 0
0 0 0 0
0 0 0
0 0 0
2
1


H
H
k
k
F
  












  
  
  
  

C
CT
H
HT
V
   
   
  
  
0 1 1
0
0 0 1 0
0 0 0 1
4 3
4 3
6
5
 
Using Maple 6.0, we used the Next Generator 
Process to find the exact value of  R0 using the two 
vectors above.  
1 6
2
0   

H
H
U
k
R
  

  
1 5
1
0   

HT
H
T
k
R
  

 
If R0U is less than 1 and R0T is less than 1, then the 
system of differential equations is stable. This means 
the  DE  is  asymptotically  stable.  The  values  for  the 
parameters were found from various sources in the 
literature. 
Results and Conclusion 
Analytical  results  of  the  model  show  that  the 
quantity R0U   is  directly  proportional  to  the  rate  of 
infectivity of HPVU and inversely proportional to the 
rates  of  HPVU  recovery  and  the  mortality  rate  of 
HPVU (natural and due to HPVU) population. Simi-
larly, R0T  is directly proportional to the rate of infec-
tivity of HPVT and inversely proportional to the rates 
of  HPVT  recovery  and  the  mortality  rate  of  HPVT 
(natural and due to HPVT) population. The results of 
the numerical simulations, using data from different 
sources in the literature [1-7], and other resources like 
CDC, confirmed and extended the analytic results. 
All state equations in the model were approxi-
mated using the Runge-Kutta 4th order numerical ap-
proximation method using MatLab software. Figure 2 
(a)  shows  the  behavior  of  the  susceptible  compart-
ment (S) with time. The graph is decreasing and has a 
negative slope. As time increases the number of those 
susceptible decreases but never disappears. Figure 2 
(b)  is  the  compartment  of  HPV  infected  without 
treatment (IHPVU). With time it gets very close to zero 
to almost nonexistent. This is because the body could 
have naturally healed. Figure 2 (c) is of the compart-
ment  of  HPV  infected  with  treatment  (IHPVT).  The 
graph  decreases  over  time  because  there  are  more 
treatment options such as vaccines and surgery. Fig-
ure 2 (d) is of the compartment of cervical cancer un-
treated (ICCU). The graph increases then decreases and 
gets closer but never reaches zero. Figure 2 (e) is of the 
compartment of cervical cancer with treatment (ICCT). 
The graph steadily decreases with time because the 
survival rate with treatment is high.  
 
 
 
 
Figure 2: Simulation Graph Results of the five compartments: (a) the Susceptible (S) population compartment, (b) HPV infected untreated 
(IHPVU) compartment, (c) HPV infected with treatment (IHPVT) compartment, (d) Cervical Cancer untreated (ICCU) compartment, and (e) 
Cervical Cancer with treatment (ICCT) compartment. 
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The basic reproductive number R0U is a directly 
proportional rate of infectivity of HPV HPVU and the 
contact rate in which a human infects another human 
with HPV and indirectly proportional to the recovery 
rate plus the mortality by natural causes and the dis-
ease. R0T is directly proportional to the rate of infec-
tivity of HPVT and contact rate in which an infected 
person  infects  another  person  with  HPV  and  indi-
rectly proportional to the recovery rate plus the mor-
tality  from  HPV  related  causes  and  natural  causes. 
This model shows that there is a direct relationship 
between HPV and cervical cancer. These results can 
be used to test the efficacy of new methods of treat-
ment that will decrease the rate of infectivity of HPV 
and cervical cancer with time.  
Mathematical  models,  from  individual  and 
population perspectives, will help decision makers to 
evaluate different prevention and mitigation scenari-
os of HPV. It can deploy synergistically to improve 
cancer outcomes, reduce disparities, and enhance the 
cost-effectiveness  of  CC  control.  Integrating  the 
best-available  epidemiologic  data,  computer-based 
mathematical  models  used  in  a  decision-analytic 
framework can identify those factors most  likely to 
influence  outcomes  and  can  inform  decisions  that 
need to be made amidst considerable lack of data and 
uncertainty. 
Given  the  inevitable  uncertainty  around  input 
parameters to any mathematical model, an important 
feature of many modeling efforts is the calibration of 
these parameter values in reference to observed epi-
demiologic data. 
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